Patent · US Active

Immunoproteases

US9944706B2 · kind B2 · utility

0Cited by

2References

19Claims

0Family size

Assignee

Fraunhofer-Gesellschaft zur förderung der angewandten Forschung e.V. · DE

Inventors

Stefan Barth · Jena, DE
Sonja Schiffer · Frechen, DE

Key dates

Filing date	Nov 4, 2013
Grant date	Apr 17, 2018
Priority date	—
Expiry date	Nov 4, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The technology provided herein relates to novel immunoproteases suitable to induce apotosis in selected diseased target cells, comprising the serine protease granzyme M, and methods for using such cytolytic fusion proteins for the treatment of various diseases, in particular for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.